Effects of GLP-1 Receptor Agonist Treatment on Pulmonary Function and Quality of Life in Obese Patients With Chronic Obstructive Pulmonary Disease.
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Liraglutide (Primary)
- Indications Chronic obstructive pulmonary disease; Obesity
- Focus Therapeutic Use
- 20 Mar 2018 New trial record